首页> 美国卫生研究院文献>BioMed Research International >A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
【2h】

A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China

机译:浙江省结核分枝杆菌复合体的遗传多样性和药物敏感性模式初探

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, our aim was to determine the predominant genotypes among the Mycobacterium tuberculosis (MTB) strains circulating in Zhejiang Province. In addition, we also sought to determine the potential associations between MTB genotypes and susceptibility to first-line drugs. Out of these isolates, 673 (71.6%) were classified into the Beijing genotype, while the other 267 (28.4%) were from non-Beijing families. The highest proportion of Beijing genotype was found in Huzhou (80.0%) and the lowest in Lishui (48.3%). Statistical analysis revealed that there was a significant difference in the prevalence of Beijing genotype among different regions (χ 2 = 17.57, P = 0.04). In addition, the overall proportions of drug resistance to INH, RIF, SM, and EMB were 13.2% (124/940), 21.8% (75/940), 3.4% (32/940), and 5.9% (55/940) in Zhejiang, respectively. Further comparison revealed that there was no significant difference in drug susceptibility profiles between Beijing and non-Beijing strains (P > 0.05). In conclusion, we describe the genetic diversity and drug susceptibility pattern of MTB in Zhejiang for the first time. Our data demonstrate that Beijing genotype is the predominant lineage in Zhejiang, while the distribution of Beijing-genotype strains shows geographic diversity. In addition, no correlation is observed between Beijing genotype and anti-TB drug resistance.
机译:在这项研究中,我们的目的是确定在浙江省流行的结核分枝杆菌(MTB)菌株中的主要基因型。此外,我们还试图确定MTB基因型与对一线药物的敏感性之间的潜在关联。在这些分离株中,有673(71.6%)属于北京基因型,而其他267(28.4%)来自非北京家庭。北京基因型比例最高的是湖州(80.0%),最低的是丽水(48.3%)。统计分析表明,北京地区不同地区的北京基因型患病率存在​​显着差异(χ 2 = 17.57,P = 0.04)。此外,对INH,RIF,SM和EMB的总耐药率分别为13.2%(124/940),21.8%(75/940),3.4%(32/940)和5.9%(55/940) )分别在浙江。进一步的比较表明,北京菌株与非北京菌株之间的药敏曲线没有显着差异(P> 0.05)。总之,我们首次描述了浙江山地车的遗传多样性和药物敏感性模式。我们的数据表明,北京基因型是浙江的主要血统,而北京基因型菌株的分布则显示出地理多样性。此外,北京基因型与抗结核药物耐药性之间没有相关性。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号